Results 261 to 270 of about 712,631 (292)
Some of the next articles are maybe not open access.

The Role of Prostaglandin Pathway and EP Receptors in Skin Cancer Development

International Journal of Dermatology
ABSTRACTSkin cancer is the most prevalent malignancy worldwide, with nonmelanoma skin cancers (NMSC) such as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) constituting most cases. Melanoma, although less common, is the most aggressive form of skin cancer and is responsible for the majority of skin cancer‐related deaths.
Anna St. Denis   +3 more
openaire   +2 more sources

Prostaglandin E2 as a mediator of fever: the role of prostaglandin E (EP) receptors

Frontiers in Bioscience, 2004
Prostaglandin E2 (PGE2) is a principal fever mediator that induces hyperthermia when injected into the organum vasculosum lamina terminalis (OVLT) and the adjacent preoptic area of the hypothalamus (POA). PGE (EP) receptors have four subtypes, i.e. EP1, EP2, EP3, and EP4. In the rat OVLT/POA region, at least three of these receptors, i.e. EP1, EP3, and
openaire   +2 more sources

Transcriptional control of energy metabolism by nuclear receptors

Nature Reviews Molecular Cell Biology, 2022
Vincent Giguere, Charlotte Scholtes
exaly  

EP receptors in NSCLC, and their regulation by epigenetic modifications

Lung Cancer, 2008
S.G. Gray, N. Al-Sarraf, K.J. O'Byrne
openaire   +1 more source

Mutual potentiation of plant immunity by cell-surface and intracellular receptors

Nature, 2021
Pok Man Ngou   +2 more
exaly  

Novel EP receptor ligands

Expert Opinion on Therapeutic Patents, 2000
openaire   +1 more source

Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors

Nature Reviews Molecular Cell Biology, 2016
Stephen Hammes, Ellis Levin
exaly  

Conducting Nanomaterial Sensor Using Natural Receptors

Chemical Reviews, 2019
Jyongsik Jang   +2 more
exaly  

Muscarinic acetylcholine receptors: novel opportunities for drug development

Nature Reviews Drug Discovery, 2014
Brian Kobilka   +2 more
exaly  

Home - About - Disclaimer - Privacy